Norepinephrine (Levophed) 1ST LINE | 0.01โ3 mcg/kg/min | ฮฑโ>>ฮฒโ | First-line in septic shock (conditional recommendation per SSC 2026). โ SVR + mild inotropy. SSC, 2026 | - |
Vasopressin (Vasostrict) ADD-ON | 0.03 units/min (fixed, no titration) | V1/V2 | Add-on to NE (NE-sparing). May reduce AKI. Add when NE โฅ 0.25โ0.5 mcg/kg/min. VASST, 2008 | Coronary vasospasm, mesenteric ischemia at higher doses |
Epinephrine (Adrenalin) 2ND LINE | 0.01โ0.5 mcg/kg/min | ฮฑโ, ฮฒโ, ฮฒโ | Refractory shock. Strong inotropy + vasoconstriction. Also cardiac arrest. | Falsely elevates lactate (ฮฒโ-mediated aerobic glycolysis) -can't use lactate to guide resuscitation |
Phenylephrine (Neo-Synephrine) 3RD LINE | 0.5โ6 mcg/kg/min | ฮฑโ pure | Use if tachyarrhythmia limits NE use. Pure vasoconstriction. | Low CO states (no inotropy -worsens cardiac output) |
Dobutamine (Dobutrex) INOTROPE | 2โ20 mcg/kg/min | ฮฒโ>ฮฒโ | Low CO despite adequate MAP (cardiogenic component). Not a vasopressor -an inotrope. | Never use alone if MAP < 65 (drops SVR via ฮฒโ). Always pair with NE. |
Milrinone (Primacor) INOTROPE | 0.125โ0.75 mcg/kg/min | PDE3 inhibitor | Inodilator. RV failure, pulmonary HTN, post-cardiac surgery. Inotropy + โ PVR. | Hypotension (vasodilation). Renally cleared -dose-adjust in AKI. |
Angiotensin II (Giapreza) LAST RESORT | 20โ200 ng/kg/min | AT1 receptor | Catecholamine-refractory vasodilatory shock. ATHOS-3, 2017 | Thrombosis risk. Very expensive. Last-line agent. |
Dopamine (Intropin) AVOID | 2โ20 mcg/kg/min | D1, ฮฒโ, ฮฑโ (dose-dependent) | AVOID in sepsis. More arrhythmias, higher mortality vs NE. SOAP II, 2010 | Avoid. Only remaining role: symptomatic bradycardia if no pacing available. |